Use of prostaglandins in cardiopulmonary diseases of the newborn.
D000818:Animals; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy; D011464:Epoprostenol / Q000627:therapeutic use; D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D007231:Infant, Newborn; D008168:Lung / Q000187:drug effects; D011247:Pregnancy; D011453:Prostaglandins / Q000494:pharmacology; D011458:Prostaglandins E / Q000009:adverse effects / Q000627:therapeutic use*; D011652:Pulmonary Circulation; D014261:Tricuspid Valve / Q000002:abnormalities
D011453:Prostaglandins; D011458:Prostaglandins E; D011464:Epoprostenol